Dermal Fillers and Botulinum Toxin - Global and China Top Players Market Share and Ranking 2023
According to Latest Study, the global market for Dermal Fillers and Botulinum Toxin should grow from US$ 13080 million in 2022 to US$ 26330 million by 2029, with a CAGR of 10.3% for the period of 2023-2029.
Global key players of dermal fillers and botulinum toxin include AbbVie, Galderma, LG Life Sciences, etc. The top three players hold a share about 72%. Americas is the largest market, has a share about 58%, followed by Europe and Asia-Pacific, with share 21% and 18%, separately.
Dermal fillers help to diminish facial lines and restore volume and fullness in the face. Dermal fillers can be used to: plump thin lips, enhance shallow contours, soften facial creases and wrinkles and improve the appearance of recessed scars. Dermal fillers can be very helpful in those with early signs of aging, or as a value-added part of facial rejuvenation surgery. Botulinum toxin (BTX) is a neurotoxic protein produced by the bacterium Clostridium botulinum and related species. It prevents the release of the neurotransmitter acetylcholine from axon endings at the neuromuscular junction and thus causes flaccid paralysis. Infection with the bacterium causes the disease botulism. The toxin is also used commercially in medicine, cosmetics and research.
This report studies and analyses global Dermal Fillers and Botulinum Toxin status and future trends, helps the client to determine the Dermal Fillers and Botulinum Toxin market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Dermal Fillers and Botulinum Toxin, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Dermal Fillers and Botulinum Toxin market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Units)
(2) Global Dermal Fillers and Botulinum Toxin sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(3) China Dermal Fillers and Botulinum Toxin sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(4) Global Dermal Fillers and Botulinum Toxin key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Dermal Fillers and Botulinum Toxin key producing regions, capacity, production, and year over year growth
(6) Dermal Fillers and Botulinum Toxin industry chains, upstream, midstream and downstream
Market segment by players, this report covers
AbbVie
Galderma
LG Life Sciences
Merz
Medytox
Hugel
Croma-Pharma
Beijing IMEIK
Bloomage Bio
Elravie (Humedix)
Cleviel (Pharma Research Products)
Haohai Biological
Teoxane
Sinclair
Suneva Medical
CG Bio
SciVision Biotech
Prollenium
Bohus BioTech
Caregen
Ipsen
LIBP
US World Meds
Daewoong
JETEMA
Market segment by Type, covers
Dermal Fillers
Botulinum Toxin
Market segment by Application, can be divided into
Cosmetic
Medical
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Dermal Fillers and Botulinum Toxin product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Dermal Fillers and Botulinum Toxin market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China Dermal Fillers and Botulinum Toxin market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of Dermal Fillers and Botulinum Toxin, percent & CAGR, 2018-2029
Chapter 5: Dermal Fillers and Botulinum Toxin industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Dermal Fillers and Botulinum Toxin Definition
1.2 Global Dermal Fillers and Botulinum Toxin Market Size and Forecast
1.2.1 By Consumption Value, Global Dermal Fillers and Botulinum Toxin Market Size，2018-2029
1.2.2 By Sales Quantity, Global Dermal Fillers and Botulinum Toxin Market Size，2018-2029
1.2.3 Global Dermal Fillers and Botulinum Toxin Average Selling Price (ASP)，2018-2029
1.3 China Dermal Fillers and Botulinum Toxin Market Size and Forecast
1.3.1 By Consumption Value, China Dermal Fillers and Botulinum Toxin Market Size，2018-2029
1.3.2 By Sales Quantity, China Dermal Fillers and Botulinum Toxin Market Size，2018-2029
1.3.3 China Dermal Fillers and Botulinum Toxin Average Selling Price (ASP)， 2018-2029
1.4 Share of China Dermal Fillers and Botulinum Toxin Market with Respect to the Global Market
1.4.1 By Consumption Value, China Dermal Fillers and Botulinum Toxin Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China Dermal Fillers and Botulinum Toxin Market Share in Global, 2018-2029
1.4.3 Dermal Fillers and Botulinum Toxin Market Size: China VS Global, 2018-2029
1.5 Dermal Fillers and Botulinum Toxin Market Dynamics
1.5.1 Dermal Fillers and Botulinum Toxin Market Drivers
1.5.2 Dermal Fillers and Botulinum Toxin Market Restraints
1.5.3 Dermal Fillers and Botulinum Toxin Industry Trends
1.5.4 Dermal Fillers and Botulinum Toxin Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Dermal Fillers and Botulinum Toxin, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of Dermal Fillers and Botulinum Toxin, Global Market Share by Company, 2018-2023
2.3 Dermal Fillers and Botulinum Toxin Average Selling Price (ASP) by Company, 2018-2023
2.4 Global Dermal Fillers and Botulinum Toxin Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Dermal Fillers and Botulinum Toxin Concentration Ratio
2.6 Global Dermal Fillers and Botulinum Toxin Mergers & Acquisitions, Expansion Plans
2.7 Global Dermal Fillers and Botulinum Toxin Manufacturers Product Type
2.8 Head Office and Dermal Fillers and Botulinum Toxin Production Site of Key Manufacturer
2.9 Dermal Fillers and Botulinum Toxin Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Dermal Fillers and Botulinum Toxin, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of Dermal Fillers and Botulinum Toxin, China Market Share by Company, 2018-2023
3.3 China Dermal Fillers and Botulinum Toxin Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Dermal Fillers and Botulinum Toxin Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global Dermal Fillers and Botulinum Toxin Capacity by Region
4.3 Global Dermal Fillers and Botulinum Toxin Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global Dermal Fillers and Botulinum Toxin Production by Region, 2018-2029
4.5 Global Dermal Fillers and Botulinum Toxin Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Dermal Fillers and Botulinum Toxin Industry Chain
5.2 Dermal Fillers and Botulinum Toxin Upstream Analysis
5.2.1 Dermal Fillers and Botulinum Toxin Core Raw Materials
5.2.2 Main Manufacturers of Dermal Fillers and Botulinum Toxin Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Dermal Fillers and Botulinum Toxin Production Mode
5.6 Dermal Fillers and Botulinum Toxin Procurement Model
5.7 Dermal Fillers and Botulinum Toxin Industry Sales Model and Sales Channels
5.7.1 Dermal Fillers and Botulinum Toxin Sales Model
5.7.2 Dermal Fillers and Botulinum Toxin Typical Distributors
6 Sights by Type
6.1 Dermal Fillers and Botulinum Toxin Classification
6.1.1 Dermal Fillers
6.1.2 Botulinum Toxin
6.2 By Type, Global Dermal Fillers and Botulinum Toxin Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Dermal Fillers and Botulinum Toxin Consumption Value, 2018-2029
6.4 By Type, Global Dermal Fillers and Botulinum Toxin Sales Quantity, 2018-2029
6.5 By Type, Global Dermal Fillers and Botulinum Toxin Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 Dermal Fillers and Botulinum Toxin Segment by Application
7.1.1 Cosmetic
7.1.2 Medical
7.2 By Application, Global Dermal Fillers and Botulinum Toxin Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Dermal Fillers and Botulinum Toxin Consumption Value, 2018-2029
7.4 By Application, Global Dermal Fillers and Botulinum Toxin Sales Quantity, 2018-2029
7.5 By Application, Global Dermal Fillers and Botulinum Toxin Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Dermal Fillers and Botulinum Toxin Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global Dermal Fillers and Botulinum Toxin Consumption Value, 2018-2029
8.3 By Region, Global Dermal Fillers and Botulinum Toxin Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America Dermal Fillers and Botulinum Toxin & Forecasts, 2018-2029
8.4.2 By Country, North America Dermal Fillers and Botulinum Toxin Market Size Market Share
8.5 Europe
8.5.1 Europe Dermal Fillers and Botulinum Toxin Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Dermal Fillers and Botulinum Toxin Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Dermal Fillers and Botulinum Toxin Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Dermal Fillers and Botulinum Toxin Market Size Market Share
8.7 South America
8.7.1 South America Dermal Fillers and Botulinum Toxin Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Dermal Fillers and Botulinum Toxin Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Dermal Fillers and Botulinum Toxin Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global Dermal Fillers and Botulinum Toxin Consumption Value, 2018-2029
9.3 By Country, Global Dermal Fillers and Botulinum Toxin Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. Dermal Fillers and Botulinum Toxin Market Size, 2018-2029
9.4.2 By Type, U.S. Dermal Fillers and Botulinum Toxin Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. Dermal Fillers and Botulinum Toxin Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Dermal Fillers and Botulinum Toxin Market Size, 2018-2029
9.5.2 By Type, Europe Dermal Fillers and Botulinum Toxin Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe Dermal Fillers and Botulinum Toxin Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China Dermal Fillers and Botulinum Toxin Market Size, 2018-2029
9.6.2 By Type, China Dermal Fillers and Botulinum Toxin Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China Dermal Fillers and Botulinum Toxin Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Dermal Fillers and Botulinum Toxin Market Size, 2018-2029
9.7.2 By Type, Japan Dermal Fillers and Botulinum Toxin Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan Dermal Fillers and Botulinum Toxin Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Dermal Fillers and Botulinum Toxin Market Size, 2018-2029
9.8.2 By Type, South Korea Dermal Fillers and Botulinum Toxin Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea Dermal Fillers and Botulinum Toxin Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Dermal Fillers and Botulinum Toxin Market Size, 2018-2029
9.9.2 By Type, Southeast Asia Dermal Fillers and Botulinum Toxin Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia Dermal Fillers and Botulinum Toxin Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India Dermal Fillers and Botulinum Toxin Market Size, 2018-2029
9.10.2 By Type, India Dermal Fillers and Botulinum Toxin Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India Dermal Fillers and Botulinum Toxin Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa Dermal Fillers and Botulinum Toxin Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa Dermal Fillers and Botulinum Toxin Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa Dermal Fillers and Botulinum Toxin Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 AbbVie
10.1.1 AbbVie Company Information, Head Office, Market Area, and Industry Position
10.1.2 AbbVie Dermal Fillers and Botulinum Toxin Models, Specifications, and Application
10.1.3 AbbVie Dermal Fillers and Botulinum Toxin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 AbbVie Company Profile and Main Business
10.1.5 AbbVie Recent Developments
10.2 Galderma
10.2.1 Galderma Company Information, Head Office, Market Area, and Industry Position
10.2.2 Galderma Dermal Fillers and Botulinum Toxin Models, Specifications, and Application
10.2.3 Galderma Dermal Fillers and Botulinum Toxin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Galderma Company Profile and Main Business
10.2.5 Galderma Recent Developments
10.3 LG Life Sciences
10.3.1 LG Life Sciences Company Information, Head Office, Market Area, and Industry Position
10.3.2 LG Life Sciences Dermal Fillers and Botulinum Toxin Models, Specifications, and Application
10.3.3 LG Life Sciences Dermal Fillers and Botulinum Toxin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 LG Life Sciences Company Profile and Main Business
10.3.5 LG Life Sciences Recent Developments
10.4 Merz
10.4.1 Merz Company Information, Head Office, Market Area, and Industry Position
10.4.2 Merz Dermal Fillers and Botulinum Toxin Models, Specifications, and Application
10.4.3 Merz Dermal Fillers and Botulinum Toxin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Merz Company Profile and Main Business
10.4.5 Merz Recent Developments
10.5 Medytox
10.5.1 Medytox Company Information, Head Office, Market Area, and Industry Position
10.5.2 Medytox Dermal Fillers and Botulinum Toxin Models, Specifications, and Application
10.5.3 Medytox Dermal Fillers and Botulinum Toxin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Medytox Company Profile and Main Business
10.5.5 Medytox Recent Developments
10.6 Hugel
10.6.1 Hugel Company Information, Head Office, Market Area, and Industry Position
10.6.2 Hugel Dermal Fillers and Botulinum Toxin Models, Specifications, and Application
10.6.3 Hugel Dermal Fillers and Botulinum Toxin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Hugel Company Profile and Main Business
10.6.5 Hugel Recent Developments
10.7 Croma-Pharma
10.7.1 Croma-Pharma Company Information, Head Office, Market Area, and Industry Position
10.7.2 Croma-Pharma Dermal Fillers and Botulinum Toxin Models, Specifications, and Application
10.7.3 Croma-Pharma Dermal Fillers and Botulinum Toxin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Croma-Pharma Company Profile and Main Business
10.7.5 Croma-Pharma Recent Developments
10.8 Beijing IMEIK
10.8.1 Beijing IMEIK Company Information, Head Office, Market Area, and Industry Position
10.8.2 Beijing IMEIK Dermal Fillers and Botulinum Toxin Models, Specifications, and Application
10.8.3 Beijing IMEIK Dermal Fillers and Botulinum Toxin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Beijing IMEIK Company Profile and Main Business
10.8.5 Beijing IMEIK Recent Developments
10.9 Bloomage Bio
10.9.1 Bloomage Bio Company Information, Head Office, Market Area, and Industry Position
10.9.2 Bloomage Bio Dermal Fillers and Botulinum Toxin Models, Specifications, and Application
10.9.3 Bloomage Bio Dermal Fillers and Botulinum Toxin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Bloomage Bio Company Profile and Main Business
10.9.5 Bloomage Bio Recent Developments
10.10 Elravie (Humedix)
10.10.1 Elravie (Humedix) Company Information, Head Office, Market Area, and Industry Position
10.10.2 Elravie (Humedix) Dermal Fillers and Botulinum Toxin Models, Specifications, and Application
10.10.3 Elravie (Humedix) Dermal Fillers and Botulinum Toxin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Elravie (Humedix) Company Profile and Main Business
10.10.5 Elravie (Humedix) Recent Developments
10.11 Cleviel (Pharma Research Products)
10.11.1 Cleviel (Pharma Research Products) Company Information, Head Office, Market Area, and Industry Position
10.11.2 Cleviel (Pharma Research Products) Dermal Fillers and Botulinum Toxin Models, Specifications, and Application
10.11.3 Cleviel (Pharma Research Products) Dermal Fillers and Botulinum Toxin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Cleviel (Pharma Research Products) Company Profile and Main Business
10.11.5 Cleviel (Pharma Research Products) Recent Developments
10.12 Haohai Biological
10.12.1 Haohai Biological Company Information, Head Office, Market Area, and Industry Position
10.12.2 Haohai Biological Dermal Fillers and Botulinum Toxin Models, Specifications, and Application
10.12.3 Haohai Biological Dermal Fillers and Botulinum Toxin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Haohai Biological Company Profile and Main Business
10.12.5 Haohai Biological Recent Developments
10.13 Teoxane
10.13.1 Teoxane Company Information, Head Office, Market Area, and Industry Position
10.13.2 Teoxane Dermal Fillers and Botulinum Toxin Models, Specifications, and Application
10.13.3 Teoxane Dermal Fillers and Botulinum Toxin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Teoxane Company Profile and Main Business
10.13.5 Teoxane Recent Developments
10.14 Sinclair
10.14.1 Sinclair Company Information, Head Office, Market Area, and Industry Position
10.14.2 Sinclair Dermal Fillers and Botulinum Toxin Models, Specifications, and Application
10.14.3 Sinclair Dermal Fillers and Botulinum Toxin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Sinclair Company Profile and Main Business
10.14.5 Sinclair Recent Developments
10.15 Suneva Medical
10.15.1 Suneva Medical Company Information, Head Office, Market Area, and Industry Position
10.15.2 Suneva Medical Dermal Fillers and Botulinum Toxin Models, Specifications, and Application
10.15.3 Suneva Medical Dermal Fillers and Botulinum Toxin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.15.4 Suneva Medical Company Profile and Main Business
10.15.5 Suneva Medical Recent Developments
10.16 CG Bio
10.16.1 CG Bio Company Information, Head Office, Market Area, and Industry Position
10.16.2 CG Bio Dermal Fillers and Botulinum Toxin Models, Specifications, and Application
10.16.3 CG Bio Dermal Fillers and Botulinum Toxin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.16.4 CG Bio Company Profile and Main Business
10.16.5 CG Bio Recent Developments
10.17 SciVision Biotech
10.17.1 SciVision Biotech Company Information, Head Office, Market Area, and Industry Position
10.17.2 SciVision Biotech Dermal Fillers and Botulinum Toxin Models, Specifications, and Application
10.17.3 SciVision Biotech Dermal Fillers and Botulinum Toxin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.17.4 SciVision Biotech Company Profile and Main Business
10.17.5 SciVision Biotech Recent Developments
10.18 Prollenium
10.18.1 Prollenium Company Information, Head Office, Market Area, and Industry Position
10.18.2 Prollenium Dermal Fillers and Botulinum Toxin Models, Specifications, and Application
10.18.3 Prollenium Dermal Fillers and Botulinum Toxin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.18.4 Prollenium Company Profile and Main Business
10.18.5 Prollenium Recent Developments
10.19 Bohus BioTech
10.19.1 Bohus BioTech Company Information, Head Office, Market Area, and Industry Position
10.19.2 Bohus BioTech Dermal Fillers and Botulinum Toxin Models, Specifications, and Application
10.19.3 Bohus BioTech Dermal Fillers and Botulinum Toxin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.19.4 Bohus BioTech Company Profile and Main Business
10.19.5 Bohus BioTech Recent Developments
10.20 Caregen
10.20.1 Caregen Company Information, Head Office, Market Area, and Industry Position
10.20.2 Caregen Dermal Fillers and Botulinum Toxin Models, Specifications, and Application
10.20.3 Caregen Dermal Fillers and Botulinum Toxin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.20.4 Caregen Company Profile and Main Business
10.20.5 Caregen Recent Developments
10.21 Ipsen
10.21.1 Ipsen Company Information, Head Office, Market Area, and Industry Position
10.21.2 Ipsen Dermal Fillers and Botulinum Toxin Models, Specifications, and Application
10.21.3 Ipsen Dermal Fillers and Botulinum Toxin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.21.4 Ipsen Company Profile and Main Business
10.21.5 Ipsen Recent Developments
10.22 LIBP
10.22.1 LIBP Company Information, Head Office, Market Area, and Industry Position
10.22.2 LIBP Dermal Fillers and Botulinum Toxin Models, Specifications, and Application
10.22.3 LIBP Dermal Fillers and Botulinum Toxin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.22.4 LIBP Company Profile and Main Business
10.22.5 LIBP Recent Developments
10.23 US World Meds
10.23.1 US World Meds Company Information, Head Office, Market Area, and Industry Position
10.23.2 US World Meds Dermal Fillers and Botulinum Toxin Models, Specifications, and Application
10.23.3 US World Meds Dermal Fillers and Botulinum Toxin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.23.4 US World Meds Company Profile and Main Business
10.23.5 US World Meds Recent Developments
10.24 Daewoong
10.24.1 Daewoong Company Information, Head Office, Market Area, and Industry Position
10.24.2 Daewoong Dermal Fillers and Botulinum Toxin Models, Specifications, and Application
10.24.3 Daewoong Dermal Fillers and Botulinum Toxin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.24.4 Daewoong Company Profile and Main Business
10.24.5 Daewoong Recent Developments
10.25 JETEMA
10.25.1 JETEMA Company Information, Head Office, Market Area, and Industry Position
10.25.2 JETEMA Dermal Fillers and Botulinum Toxin Models, Specifications, and Application
10.25.3 JETEMA Dermal Fillers and Botulinum Toxin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.25.4 JETEMA Company Profile and Main Business
10.25.5 JETEMA Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Dermal Fillers and Botulinum Toxin Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Dermal Fillers and Botulinum Toxin Market Restraints
Table 3. Dermal Fillers and Botulinum Toxin Market Trends
Table 4. Dermal Fillers and Botulinum Toxin Industry Policy
Table 5. Global Dermal Fillers and Botulinum Toxin Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Dermal Fillers and Botulinum Toxin Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Dermal Fillers and Botulinum Toxin Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 8. Global Dermal Fillers and Botulinum Toxin Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Dermal Fillers and Botulinum Toxin Average Selling Price (ASP) by Company, (2018-2023) & (USD/Unit)
Table 10. Global Dermal Fillers and Botulinum Toxin Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Dermal Fillers and Botulinum Toxin Mergers & Acquisitions, Expansion Plans
Table 12. Global Dermal Fillers and Botulinum Toxin Manufacturers Product Type
Table 13. Head Office and Dermal Fillers and Botulinum Toxin Production Site of Key Manufacturer
Table 14. Dermal Fillers and Botulinum Toxin Capacity of Major Manufacturers and Future Plan
Table 15. China Dermal Fillers and Botulinum Toxin Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Dermal Fillers and Botulinum Toxin Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 17. China Dermal Fillers and Botulinum Toxin Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Dermal Fillers and Botulinum Toxin Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 19. Global Dermal Fillers and Botulinum Toxin Production by Region, 2018-2023, (K Units)
Table 20. Global Dermal Fillers and Botulinum Toxin Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of Dermal Fillers and Botulinum Toxin Upstream (Raw Materials)
Table 22. Global Dermal Fillers and Botulinum Toxin Typical Customers
Table 23. Dermal Fillers and Botulinum Toxin Typical Distributors
Table 24. By Type, Global Dermal Fillers and Botulinum Toxin Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Dermal Fillers and Botulinum Toxin Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Dermal Fillers and Botulinum Toxin Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Dermal Fillers and Botulinum Toxin Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Dermal Fillers and Botulinum Toxin Sales Quantity, 2018-2029, (K Units)
Table 29. By Country, Global Dermal Fillers and Botulinum Toxin Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Dermal Fillers and Botulinum Toxin Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Dermal Fillers and Botulinum Toxin Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Dermal Fillers and Botulinum Toxin Sales Quantity, 2018-2029, (K Units)
Table 33. By Country, Global Dermal Fillers and Botulinum Toxin Sales Quantity Market Share, 2018-2029
Table 34. AbbVie Company Information, Head Office, Market Area, and Industry Position
Table 35. AbbVie Dermal Fillers and Botulinum Toxin Models, Specifications, and Application
Table 36. AbbVie Dermal Fillers and Botulinum Toxin Sales Quantity (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, 2018-2023
Table 37. AbbVie Company Profile and Main Business
Table 38. AbbVie Recent Developments
Table 39. Galderma Company Information, Head Office, Market Area, and Industry Position
Table 40. Galderma Dermal Fillers and Botulinum Toxin Models, Specifications, and Application
Table 41. Galderma Dermal Fillers and Botulinum Toxin Sales Quantity (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, 2018-2023
Table 42. Galderma Company Profile and Main Business
Table 43. Galderma Recent Developments
Table 44. LG Life Sciences Company Information, Head Office, Market Area, and Industry Position
Table 45. LG Life Sciences Dermal Fillers and Botulinum Toxin Models, Specifications, and Application
Table 46. LG Life Sciences Dermal Fillers and Botulinum Toxin Sales Quantity (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, 2018-2023
Table 47. LG Life Sciences Company Profile and Main Business
Table 48. LG Life Sciences Recent Developments
Table 49. Merz Company Information, Head Office, Market Area, and Industry Position
Table 50. Merz Dermal Fillers and Botulinum Toxin Models, Specifications, and Application
Table 51. Merz Dermal Fillers and Botulinum Toxin Sales Quantity (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, 2018-2023
Table 52. Merz Company Profile and Main Business
Table 53. Merz Recent Developments
Table 54. Medytox Company Information, Head Office, Market Area, and Industry Position
Table 55. Medytox Dermal Fillers and Botulinum Toxin Models, Specifications, and Application
Table 56. Medytox Dermal Fillers and Botulinum Toxin Sales Quantity (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, 2018-2023
Table 57. Medytox Company Profile and Main Business
Table 58. Medytox Recent Developments
Table 59. Hugel Company Information, Head Office, Market Area, and Industry Position
Table 60. Hugel Dermal Fillers and Botulinum Toxin Models, Specifications, and Application
Table 61. Hugel Dermal Fillers and Botulinum Toxin Sales Quantity (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, 2018-2023
Table 62. Hugel Company Profile and Main Business
Table 63. Hugel Recent Developments
Table 64. Croma-Pharma Company Information, Head Office, Market Area, and Industry Position
Table 65. Croma-Pharma Dermal Fillers and Botulinum Toxin Models, Specifications, and Application
Table 66. Croma-Pharma Dermal Fillers and Botulinum Toxin Sales Quantity (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, 2018-2023
Table 67. Croma-Pharma Company Profile and Main Business
Table 68. Croma-Pharma Recent Developments
Table 69. Beijing IMEIK Company Information, Head Office, Market Area, and Industry Position
Table 70. Beijing IMEIK Dermal Fillers and Botulinum Toxin Models, Specifications, and Application
Table 71. Beijing IMEIK Dermal Fillers and Botulinum Toxin Sales Quantity (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, 2018-2023
Table 72. Beijing IMEIK Company Profile and Main Business
Table 73. Beijing IMEIK Recent Developments
Table 74. Bloomage Bio Company Information, Head Office, Market Area, and Industry Position
Table 75. Bloomage Bio Dermal Fillers and Botulinum Toxin Models, Specifications, and Application
Table 76. Bloomage Bio Dermal Fillers and Botulinum Toxin Sales Quantity (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, 2018-2023
Table 77. Bloomage Bio Company Profile and Main Business
Table 78. Bloomage Bio Recent Developments
Table 79. Elravie (Humedix) Company Information, Head Office, Market Area, and Industry Position
Table 80. Elravie (Humedix) Dermal Fillers and Botulinum Toxin Models, Specifications, and Application
Table 81. Elravie (Humedix) Dermal Fillers and Botulinum Toxin Sales Quantity (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, 2018-2023
Table 82. Elravie (Humedix) Company Profile and Main Business
Table 83. Elravie (Humedix) Recent Developments
Table 84. Cleviel (Pharma Research Products) Company Information, Head Office, Market Area, and Industry Position
Table 85. Cleviel (Pharma Research Products) Dermal Fillers and Botulinum Toxin Models, Specifications, and Application
Table 86. Cleviel (Pharma Research Products) Dermal Fillers and Botulinum Toxin Sales Quantity (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, 2018-2023
Table 87. Cleviel (Pharma Research Products) Company Profile and Main Business
Table 88. Cleviel (Pharma Research Products) Recent Developments
Table 89. Haohai Biological Company Information, Head Office, Market Area, and Industry Position
Table 90. Haohai Biological Dermal Fillers and Botulinum Toxin Models, Specifications, and Application
Table 91. Haohai Biological Dermal Fillers and Botulinum Toxin Sales Quantity (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, 2018-2023
Table 92. Haohai Biological Company Profile and Main Business
Table 93. Haohai Biological Recent Developments
Table 94. Teoxane Company Information, Head Office, Market Area, and Industry Position
Table 95. Teoxane Dermal Fillers and Botulinum Toxin Models, Specifications, and Application
Table 96. Teoxane Dermal Fillers and Botulinum Toxin Sales Quantity (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, 2018-2023
Table 97. Teoxane Company Profile and Main Business
Table 98. Teoxane Recent Developments
Table 99. Sinclair Company Information, Head Office, Market Area, and Industry Position
Table 100. Sinclair Dermal Fillers and Botulinum Toxin Models, Specifications, and Application
Table 101. Sinclair Dermal Fillers and Botulinum Toxin Sales Quantity (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, 2018-2023
Table 102. Sinclair Company Profile and Main Business
Table 103. Sinclair Recent Developments
Table 104. Suneva Medical Company Information, Head Office, Market Area, and Industry Position
Table 105. Suneva Medical Dermal Fillers and Botulinum Toxin Models, Specifications, and Application
Table 106. Suneva Medical Dermal Fillers and Botulinum Toxin Sales Quantity (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, 2018-2023
Table 107. Suneva Medical Company Profile and Main Business
Table 108. Suneva Medical Recent Developments
Table 109. CG Bio Company Information, Head Office, Market Area, and Industry Position
Table 110. CG Bio Dermal Fillers and Botulinum Toxin Models, Specifications, and Application
Table 111. CG Bio Dermal Fillers and Botulinum Toxin Sales Quantity (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, 2018-2023
Table 112. CG Bio Company Profile and Main Business
Table 113. CG Bio Recent Developments
Table 114. SciVision Biotech Company Information, Head Office, Market Area, and Industry Position
Table 115. SciVision Biotech Dermal Fillers and Botulinum Toxin Models, Specifications, and Application
Table 116. SciVision Biotech Dermal Fillers and Botulinum Toxin Sales Quantity (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, 2018-2023
Table 117. SciVision Biotech Company Profile and Main Business
Table 118. SciVision Biotech Recent Developments
Table 119. Prollenium Company Information, Head Office, Market Area, and Industry Position
Table 120. Prollenium Dermal Fillers and Botulinum Toxin Models, Specifications, and Application
Table 121. Prollenium Dermal Fillers and Botulinum Toxin Sales Quantity (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, 2018-2023
Table 122. Prollenium Company Profile and Main Business
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|